Zhang Yong, Li Qiyuan, Wang Xian, Zhou Xiaolin
Beijing Genomics Institute (BGI), Yantian District, Shenzhen, 518083, China.
Adv Exp Med Biol. 2015;864:125-40. doi: 10.1007/978-3-319-20579-3_10.
Biobanks are playing increasingly important roles in clinical and translational research nowadays. China, as a country with the largest population and abundant clinical resources, attaches great importance to the development of biobanks. In recent years, with the increasing support from the Chinese government, biobanks are blooming across the country. This paper provides a detailed overview of China biobanking, which is further divided in the following four parts: (i) general introduction of the number, category and distribution of current biobanks; (ii) summarization of the current development status, and issues that Chinese biobanks are faced with; (iii) international cooperation between China and the global biobanking community; (iv) prospect of the modern twenty-first century Chinese biobanks, which would achieve standardized operation, systematic specimen management, and extensive collaboration, and thus provide support for the robust research discoveries and personalized medicine etc.
生物样本库如今在临床和转化研究中发挥着越来越重要的作用。中国作为人口最多且临床资源丰富的国家，高度重视生物样本库的发展。近年来，在中国政府日益加大的支持下，生物样本库在全国蓬勃发展。本文详细概述了中国的生物样本库建设情况，进一步分为以下四个部分：（i）当前生物样本库的数量、类别及分布概况；（ii）中国生物样本库目前的发展状况及面临的问题总结；（iii）中国与全球生物样本库领域的国际合作；（iv）21世纪中国现代生物样本库的展望，其将实现标准化运作、系统化样本管理以及广泛协作，从而为强大的研究发现和个性化医疗等提供支持。
